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Abstract
Rationale—Arteriogenesis, the shear stress-driven remodeling of collateral arteries, is critical in
restoring blood flow to ischemic tissue following a vascular occlusion. Our previous work has
shown that the adaptor protein Shc mediates endothelial responses to shear stress in vitro.
Objective—To examine the role of the adaptor protein Shc in arteriogenesis and endothelial-
dependent responses to shear stress in vivo.
Methods and Results—Conditional knockout mice in which Shc is deleted from endothelial
cells were subjected to femoral artery ligation. Hindlimb perfusion recovery was attenuated in Shc
conditional knockout mice compared to littermate controls. Reduced perfusion was associated
with blunted collateral remodeling and reduced capillary density. Bone marrow transplantation
experiments revealed that endothelial Shc is required for perfusion recovery as loss of Shc in bone
marrow-derived hematopoietic cells had no effect on recovery. Mechanistically, Shc deficiency
resulted in impaired activation of the NF-κB-dependent inflammatory pathway and reduced
CD45+ cell infiltration. Unexpectedly, Shc was required for arterial specification of the
remodeling arteriole by mediating upregulation of the arterial endothelial cell marker ephrinB2
and activation of the Notch pathway. In vitro experiments confirmed that Shc was required for
shear stress-induced activation of the Notch pathway and downstream arterial specification
through a mechanism that involves upregulation of Notch ligands Delta-like 1 and Delta-like 4.
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Conclusions—Shc mediates activation of two key signaling pathways that are critical for
inflammation and arterial specification; collectively, these pathways contribute to arteriogenesis
and recovery of blood perfusion.
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INTRODUCTION
Arteriogenesis, the outward remodeling of pre-existing collateral arteries, is critical in
recovery and restoration of blood supply to ischemic tissue following occlusion of a vessel.
Arteriole–arteriole anastomoses, termed collaterals, act as a natural bypass mechanism to
maintain blood supply to downstream tissue even when major arteries, such as the femoral
artery, become blocked1. Blood flow through collateral arteries in a healthy animal is
negligible, however, after an occlusion, the steep pressure gradient between the pre-and
post- occlusive regions of the vessel causes blood to rush into pre-existing collaterals and
induces outward remodeling of the vessel. Outward remodeling of preexisting collaterals is
driven primarily by the sudden spike in hemodynamic forces, especially shear stress,
resulting from the increase in flow through collaterals2. Changes in hemodynamic forces are
sensed by endothelial cells (ECs)3-5, which initiate signal transduction pathways that induce
cell proliferation and inflammation, including upregulation of cell adhesion molecules on
ECs and leukocyte accumulation in the vessel wall6.
ECs are equipped with numerous mechanoreceptors capable of responding to shear stress,
including caveolae, ion channels, integrins, Receptor Tyrosine Kinases, the apical
glycocalyx, primary cilia, heterotrimeric G proteins, and intercellular junctions4. We
previously identified a mechanosensory complex located at cell-cell junctions comprised of
Platelet Endothelial Cell Adhesion Molecule (PECAM)-1, Vascular Endothelial (VE)-
Cadherin, and Vascular Endothelial Growth Factor Receptor (VEGFR)2 that is necessary
and sufficient for EC response to shear stress in vitro 7; vascular remodeling8; and
arteriogenesis in vivo9.
The adaptor protein Shc mediates signaling cascades downstream of a multitude of Receptor
Tyrosine Kinases for various growth factors, cytokines, hormones and recently, mechanical
force10, 11. Global knockout of the Shc1 gene in mice causes embryonic lethality at E11.5
due to defects in embryonic heart development12, 13. Conditional knockout mice in which
Shc was deleted from ECs displayed a defect in post-natal angiogenesis 14. Using an in vitro
shear stress system that models the sudden increase in hemodynamic forces in collaterals
immediately following femoral artery ligation, we previously demonstrated that onset of
shear stress activates Shc and induces its association with components of the
mechanosensory complex (VE-cadherin and VEGFR2), as well as integrins15. Here, we
hypothesize that endothelial Shc is required for shear stress-driven arteriogenesis and blood
flow recovery in response to femoral artery ligation. Our data show impaired plantar
perfusion recovery in Shc flox/flox; Tie2-Cre mice, which was dependent on Shc expression
in ECs but not hematopoietic cells. Furthermore, we demonstrate that Shc is required for
activation of the NF-κB pathway and downstream inflammation in collateral arteries.
Surprisingly, Shc is also required for shear stress-induced activation of the Notch pathway
and downstream expression of the arterial EC marker ephrinB2 through a mechanism that
involves upregulation of Notch ligands Dll-1 and Dll-4.
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The materials and methods used are detailed in the Online Supplement.
RESULTS
Shc is required for plantar perfusion recovery following hindlimb ischemia
To determine the role of endothelial Shc in perfusion recovery following ischemia, Shc flox/
flox; Tie2-Cre and Shc flox/flox littermates were subjected to hindlimb ischemia by ligation
of the femoral artery, which triggers shear stress-mediated adaptive remodeling of
preexisting collaterals from the deep femoral artery. Blood perfusion of hind paws (plantar)
was non-invasively measured using Laser Doppler Imaging before surgery (pre),
immediately after surgery (acute), and at various timepoints throughout the 3 week recovery
period following surgery (Figure 1A). Plantar perfusion was quantified from the Doppler
images and normalized to the sham control side of the same animal to determine the percent
of perfusion of the ligated hindlimb compared with the unligated sham hindlimb. Strikingly,
Shc flox/flox; Tie2-Cre mice displayed attenuated perfusion recovery as early as 5 days post-
surgery (Figure 1B). The defect in perfusion recovery was exacerbated at each timepoint
until day 21, when Shc flox/flox; Tie2-Cre mice showed a 40% reduction in plantar
perfusion in compared to Shc flox/flox controls. Importantly, in wild-type mice, femoral
artery ligation induced rapid Shc phosphorylation in ECs that line pre-existing collateral
arteries (Figure 1C, Online Figure I), indicating that endothelial Shc is activated in this
model. These data demonstrate that Shc is activated in ECs during collateral remodeling and
that Shc is required for perfusion recovery following hindlimb ischemia.
Shc is required for collateral remodeling
Plantar perfusion recovery following femoral artery ligation requires two EC-dependent
vascular processes: arteriogenesis and angiogenesis 2, 16. Ligation of the femoral artery
causes a sudden increase in blood flow and hemodynamic force through pre-existing
collateral arteries in the gracilis muscles, causing flow-induced outward vascular
remodeling, therefore allowing more blood to be carried by the collateral artery.
Simultaneously, ischemia in tissues distal to the ligation, such as the gastrocnemius muscle,
induces angiogenesis in order to increase vascular density and blood perfusion. In order to
test whether Shc is required for arteriogenesis and/or angiogenesis, we examined the gracilis
and gastrocnemius muscles before and 3 weeks after ligation. At day 21 after ligation, the
collaterals in Shc flox/flox; Tie2-Cre mice were ~30% smaller than those of control Shc flox/
flox littermates, indicating defective arteriogenesis (Figure 1D). Importantly, no difference
existed between the two genotypes in basal gracilis collateral size or vascular architecture of
the gracilis muscle in un-ligated animals (Online Figure II). Similarly, induction of
angiogenesis in the ischemic gastrocnemius muscle was defective in Shc flox/flox; Tie2-Cre
mice at day 21. Capillary density increased by almost 50% in control Shc flox/flox mice,
whereas Shc flox/flox; Tie2-Cre mice were refractory to induction of angiogenesis (Online
Figure III). As arteriogenesis and collateral remodeling are the largest contributor to
perfusion recovery17 we focused our attention on the role of Shc in collateral growth.
Shc is required for shear stress-induced NF-κB dependent inflammation in collaterals
The attenuated plantar perfusion recovery and collateral remodeling in Shc flox/flox; Tie2-
Cre mice suggests a role for Shc in arteriogenesis. The sharp increase in hemodynamic
forces in the collateral induces EC proliferation and inflammation; two EC-dependent
processes that underlie arteriogenesis. We assayed EC proliferation in collaterals of Shc flox/
flox; Tie2-Cre and Shc flox/flox mice by nuclear PCNA staining. Proliferation in collaterals
3 days after surgery was decreased in Shc flox/flox; Tie2-Cre mice compared to Shc flox/flox
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controls (Figure 2A). Similarly, we assayed the role of Shc in activation of inflammation in
response to femoral artery ligation. Collaterals were stained for infiltration of CD45-positive
leukocytes, an important mediator of collateral remodeling. Shc flox/flox; Tie2-Cre mice
exhibited a significant decrease in CD45-positive leukocyte infiltration compared to Shc
flox/flox controls (Figure 2B), indicating a role for Shc in inflammation in response to
hindlimb ischemia. CD45-positive cell recruitment following femoral artery ligation
requires activation of NF-κB in ECs 18, so we tested the role of Shc in NF-κB activation in
this model. While Shc flox/flox mice showed significant activation of NF-κB as early as
24hrs after ligation, Shc flox/flox; Tie2-Cre mice displayed defects in NF-κB activation in
ECs (Figure 2C, Online Figure IV). Interestingly, we also observed upregulation of p65
expression in ECs in Shc flox/flox mice that was absent in Shc flox/flox; Tie2-Cre mice. This
defect in p65 nuclear localization coincided with a decrease in upregulation of the NF-κB-
dependent adhesion molecule Vascular Cell Adhesion Molecule-1 (VCAM-1) and
Monocyte Chemoattractant Protein-1 (Figure 2D, Online Figure V). Together, these data
indicate that Shc is required for EC proliferation and inflammation during collateral
remodeling, both of which are critical for recovery from hindlimb ischemia.
Shc expression in ECs, but not hematopoietic cells, is required for plantar perfusion
recovery, arteriogenesis and leukocyte adhesion
The Tie2 promoter used to drive Cre expression in these experiments is expressed primarily
in ECs as well as in a significant portion of bone marrow-derived hematopoietic cells 19, 20.
To determine whether Shc in ECs or hematopoietic cells determines perfusion recovery, we
performed bone marrow transplants. Four groups of mice (Shc flox/flox recipients (flox)
reconstituted with Shc flox/flox (flox) or Shc flox/flox; Tie2-Cre (KO) bone marrow and Shc
flox/flox; Tie2-Cre (KO) recipients reconstituted with Shc flox/flox or Shc flox/flox; Tie2-Cre
bone marrow) were subjected to femoral artery ligation surgery, and plantar perfusion
recovery was assessed by Laser Doppler Imaging (Figure 3A&B). Recovery of plantar
perfusion was significantly decreased in Shc flox/flox; Tie2-Cre mice reconstituted with
either Shc flox/flox or Shc flox/flox; Tie2-Cre bone marrow, whereas the recovery of the Shc
flox/flox mice reconstituted with either Shc flox/flox or Shc flox/flox; Tie2-Cre bone marrow
was normal. Similarly, remodeling of collaterals following femoral artery ligation was
defective in both the Shc flox/flox; Tie2-Cre mice reconstituted with Shc flox/flox bone
marrow and Shc flox/flox; Tie2-Cre mice reconstituted with Shc flox/flox; Tie2-Cre bone
marrow (Figure 3C). These results suggest that Shc expressed in ECs, but not hematopoietic
cells, determines arteriogenesis and plantar perfusion recovery.
To specifically test whether Shc expression in ECs and/or leukocytes is required for shear-
stress induced leukocyte adhesion to the endothelium, we performed in vitro leukocyte
adhesion assays. ECs isolated from Shc flox/flox or Shc flox/flox; Tie2-Cre mice were
subjected to inflammatory shear stress to induce cell adhesion molecule expression and
adhesion of monocytic cells (THP-1 cells) that express shRNA against Shc (shShc) or a non-
specific target (shNS) was assayed (Figure 3D). As expected, shear stress induced a 3-fold
increase in shNS monocytic cell adhesion to Shc flox/flox ECs. Interestingly, Shc flox/flox
ECs incubated with shShc monocytic cells exhibited a similar 3-fold induction, whereas no
induction of adhesion was observed in Shc flox/flox; Tie2-Cre ECs incubated with either
shNS or shShc THP-1 cells (Figure 3D). Together, these in vitro data show that Shc
expressed in ECs, but not hematopoietic cells, is required to support shear stress-induced
monocytic cell adhesion. Importantly, activation of the NF-κB pathway is required for this
response, as adhesion to the endothelium was blocked when performed in the presence of
Compound A, a specific inhibitor of Inhibitor of Kappa B Kinase-beta (IKK-β) 21 (Online
Figure VI).
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Notch-dependent collateral EC arterial specification requires Shc
The EC phenotype is plastic and heterogeneous throughout the vascular tree, and the
expression of arterial- and venous-specific genes is the consequence of local hemodynamic
cues that may regulate vessel remodeling 22, 23. Because ECs in collaterals quickly change
from a low flow environment to a high shear stress environment following femoral artery
ligation24, 25, we hypothesized that collateral ECs adopt an arterial identity to suit the new
arterial-like blood flow environment. To test this, we stained collateral tissue sections for a
marker of arterial ECs, ephrinB2 26. EphrinB2 expression was upregulated in Shc flox/flox
collateral ECs within 1-3 days after ligation, however, ephrinB2 upregulation was attenuated
in Shc flox/flox; Tie2-Cre mice, suggesting that Shc is required for arterial specification of
ECs in response to changes in the hemodynamic environment in collaterals (Figure 4A,
Online Figure IV). Because ephrinB2 is transcriptionally regulated by the Notch
transcription factor NICD 27, we next examined activation of Notch in collaterals. In control
Shc flox/flox mice, femoral artery ligation induced Notch activation (NICD nuclear
localization) in collateral ECs, whereas Notch activation was impaired in Shc flox/flox; Tie2-
Cre mice (Figure 4B-C, Online Figure IV). These data indicate that Shc is important for
activation of the Notch pathway and arterial specification of the remodeling collateral
arterioles.
ECs in collateral arteries experience several mechanical and chemical stimuli
simultaneously during arteriogenesis, making it difficult to delineate the exact role of Shc
during collateral remodeling. We therefore tested the role of Shc in shear stress-induced
Notch activation and ephrinB2 upregulation using our in vitro system. Onset of shear stress
induced expression of the Notch target genes ephrinB2, HES-1 and Deltex-1 in ECs isolated
from Shc flox/flox mice. In contrast, shear-induced upregulation of Notch target genes was
impaired in Shc knockout cells (Figure 4D). Importantly, shear stress-induced expression of
Notch target genes was impaired in wild-type ECs treated with the γ-secretase inhibitor
DAPT (Online Figure VII), indicating that shear-induced expression of these genes is
Notch-dependent. To gain mechanistic insights into the role of Shc in shear stress-induced
Notch activation, we assessed expression of Notch ligands. Notch ligands Delta-like 1
(Dll-1) and Delta-like 4 (Dll-4) were upregulated by shear stress in vitro in Shc flox/flox but
not in Shc flox/flox; Tie2-Cre ECs (Figure 4E). Shc-dependent upregulation of Dll-4 was
confirmed in collateral ECs 3 days after femoral ligation (Figure 4F), indicating that Shc
controls activation of the Notch pathway by mediating shear stress-induced upregulation of
canonical Notch ligands Dll-4 and possibly Dll-1.
DISCUSSION
Restoration of blood flow to ischemic tissue downstream of an occlusion is a highly
complex process requiring activation of several signaling pathways to induce simultaneous
angiogenesis and arteriogenesis. Here, we show that the adaptor protein Shc is instrumental
in orchestrating EC signaling during post-ischemic neovascularization following ligation of
the femoral artery. Shc flox/flox; Tie2-Cre mice in which Shc was removed from ECs
displayed a marked reduction in restoration of blood flow following femoral artery ligation.
Histological analyses revealed defects in arteriogenesis due to impaired collateral
remodeling. Mechanistically, Shc mediates vessel inflammation and activation of the
transcription factor NF-κB as well as proliferation, both of which are critical for
arteriogenesis. Unexpectedly, Shc is also required for arterial specification of the remodeling
collateral arterioles by mediating shear-induced upregulation of Notch ligands and
downstream activation of the Notch pathway, including upregulation of the arterial EC
marker ephrinB2 (Figure 4G).
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The Notch pathway is critical for embryogenesis 28 and development of the cardiovascular
system29, 30, but its role in adult physiology is less well-defined. Mice heterozygous for
Notch-1 or the Notch ligand Delta-like 1 exhibit reduced plantar perfusion recovery
following femoral artery ligation due to attenuated collateral remodelling, similar to the
phenotype observed in Shc flox/flox; Tie2-Cre mice31, 32. Similarly, inhibition of Delta-like
4 delayed plantar perfusion recovery following femoral artery ligation due to disorganized,
low perfused angiogenic sprouting in the ischemic capillary network34. Although deletion of
Shc does not affect basal collateral vessel organization, it is required for Delta-like 4
expression during collateral remodeling and in response to onset of shear stress in vitro.
Previous studies suggested that the Notch pathway is activated downstream of VEGF, which
is produced by ischemic tissue and drives angiogenesis. Here, we introduce an alternative
model in which shear stress directly activates the Notch pathway in pre-existing collateral
arterioles and results in upregulation of Notch target genes during arteriogenic remodeling
and ECs in culture. We show that activation of the Notch pathway by shear stress requires
Shc, which mediates signal transduction downstream of the mechanosensory complex of
PECAM-1, VE-Cadherin and VEGFR2 and integrins 15. Shear-stress induced activation of
the Notch pathway facilitates arterial specification of collateral ECs as they remodel into
high-flow carrying arterioles. The mechanism to explain how Notch is activated by shear
stress is currently not well understood, although our work and work of others suggests that
shear stress induces expression of Notch ligands Delta-like 1 and/or Delta-like 4, which in
turn activate Notch in trans through the canonical pathway. Similarly, it remains unclear
whether arterial-specification of ECs in remodeling arterioles is required for, or is merely a
consequence of, the remodeling process. EC-specific knockout of the arterial EC marker
ephrinB2 is embryonic lethal 33, precluding any experiments to address this question in the
adult mouse.
Hemodynamic forces, such as fluid shear stress, are the primary morphogenic cue that
induces collateral remodeling following femoral artery ligation. ECs are responsible for
sensing shear stress, and thus are equipped with numerous ‘mechanoreceptors’ capable of
sensing and responding to changes in shear stress. Two such mechanoreceptors: integrins
and a ‘mechanosensory complex’ comprised of EC-specific proteins PECAM-1, VE-
Cadherin and VEGFR2, are required for activation of inflammation in response to flow and,
thus, regulation of perfusion recovery in response to ischemic insult. We have previously
shown that Shc binds both integrins and the mechanosensory complex following onset of
flow15, and mediates signaling from these mechanoreceptors. Here, we show that Shc is
required for the EC response to changes in shear stress in vivo. Endothelial Shc relays
signals from these mechanoreceptors into whole-vessel responses, such as inflammation and
arterial specification, both of which are critical for arteriogenesis and recovery of blood flow
to ischemic tissues following an occlusion (Figure 4G).
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Nonstandard Abbreviations and Acronyms
EC Endothelial cell
PECAM-1 Platelet Endothelial Cell Adhesion Molecule-1
VEGFR2 Vascular Endothelial Growth Factor Receptor 2
VE-Cadherin Vascular Endothelial Cadherin
NF-κB Nuclear Factor kappa-light-chain-enhancer of activated B Cells
HES-1 Hairy and Enhancer of Split 1
BMT Bone Marrow Transplant
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• Collateral arteries re-route blood flow around an occluded artery to maintain
perfusion of downstream tissue.
• Collateral arteries form during embryonic development but are unused in
healthy animals unless there is an occlusion. After an occlusive event, pre-
existing collaterals remodel to larger, mature vessels.
• Collateral remodeling or arteriogenesis is driven in part by sheer stress imposed
on endothelial cells by blood flow.
• The adaptor protein Shc is regulates shear stress signaling pathways in ECs in
vitro.
What New Information Does This Article Contribute?
• Endothelial, but not hematopoietic Shc, is required for collateral remodeling and
perfusion recovery following occlusion of the femoral artery.
• Shc regulates inflammatory signaling in collateral ECs by mediating NF-κB
activation.
• Shc regulates activation of the Notch pathway and downstream arterial
specification of remodeling collaterals.
Arteriogenesis, the outward remodeling of collateral arteries in response to an increase in
blood flow, is essential for maintaining tissue perfusion following occlusion of a large
artery. Arteriogenesis is driven by increased shear stress, , but the molecular mechanism
by which ECs sense and respond to shear stress is incompletely understood. We
conditionally deleted Shc from ECs and hematopoietic cells and examined the response
to femoral artery occlusion. We found that mice lacking Shc exhibited impaired
perfusion recovery and collateral remodeling after femoral occlusion. In bone marrow
transplantation experiments, we found that endothelial, but not hematopoietic, Shc is
required for perfusion recovery. We found that, Shc is required NF-κB activation in
remodeling collaterals and for mediating shear stress-induced Notch activation via
upregulation of Notch ligands Dll-1 and Dll-4. This leads to expression of the arterial
marker ephrinB2 and arterial specification of the remodeling arteriole. These findings
contribute to our understanding of arteriogenesis, and how it could be enhanced to
prevent tissue death following vascular occlusions.
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Figure 1. Shc signaling regulates plantar perfusion recovery and arteriogenesis following
hindlimb ischemia surgery
(A) Defective perfusion recovery following femoral artery ligation in conditional knockout
Shc flox/flox; Tie2-Cre mice compared to Shc flox/flox control littermates. Representative
Laser Doppler Imaging scans of plantar perfusion before (Pre), immediately after (Acute), 7
days (7d), and 3 weeks after hindlimb ischemia surgery. Pseudocolor scale (in arbitrary
units): black indicates 0; white, 1000. (B) Ratio of plantar perfusion (ligated vs sham control
side) quantified from the Doppler images. Values are provided as mean +/− SEM. *=
p<0.05, compared with the respective time point of Shc flox/flox controls. n= 9 flox/flox and
10 flox/flox; Tie2-Cre per timepoint. (C) Representative staining of a pre-existing collateral
artery 24 hrs after ligation (or sham control). Slides were stained with phospho-Shc Y239,
240 (red), Smooth Muscle α-actin (green) and DAPI (blue). (D) Collateral lumen area in
sham and ligated hindlimbs 3 weeks after femoral artery ligation surgery in Shc flox/flox and
Shc flox/flox; Tie2-Cre mice. Cross-sections of the gracilis muscle were H&E stained and
collateral lumen area was measured. Values are provided as mean +/− SEM. *= p<0.05.
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Values are provided as mean +/− SEM. *= p<0.05. n=8 Shc flox/flox and 8 Shc flox/flox;
Tie2-Cre.
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Figure 2. Shc is required for collateral EC proliferation and inflammation
Proliferation and inflammation in the vessel wall was assessed by analyzing cross-sections
of collateral arteries 3 days after femoral after ligation (or sham) surgery. (A) Sections were
stained with PCNA to mark proliferating cells (red), Smooth Muscle α-actin (green) and
DAPI (blue). Quantitation (right) is shown as % PCNA positive ECs. (B) Quantitation of
CD-45 positive-cell accumulation in the vessel wall 3 days after surgery. (C) Staining of
collaterals for NF-κB subunit p65 (red), Smooth Muscle α-actin (green) and DAPI (blue).
Quantitation (right) displayed as % ECs with nuclear (active) p65 localization. (D) Staining
of collaterals for VCAM-1 (red), Smooth Muscle α-actin (green) and DAPI (blue). Scale
bars = 20μm. For all quantitation, values are provided as mean +/− SEM. *= p<0.05. n= 8
Shc flox/flox and 8 Shc flox/flox; Tie2-Cre
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Figure 3. Endothelial, but not hematopoietic cell Shc is required for plantar perfusion recovery,
arteriogenesis and monocyte adhesion to the endothelial monolayer
The contribution of Shc in endothelial vs. hematopoietic cells was examined by performing
bone marrow transplant and assessing recovery after femoral artery ligation. Irradiated Shc
flox/flox mice were repopulated with either Shc flox/flox; Tie2-Cre or Shc flox/flox bone
marrow. Simultaneously, irradiated Shc flox/flox; Tie2-Cre mice were repopulated with
either Shc flox/flox; Tie2-Cre or Shc flox/flox bone marrow. (A) Plantar perfusion recovery
was monitored by Laser Doppler Imaging as in Figure 1. Representative images from day 21
are shown for each condition. (B) Ratio of plantar perfusion (ligated vs sham control side)
quantified from the Doppler images. Values are provided as mean +/− SEM. *= p<0.05. n=
7 flox/flox+flox/flox BM, 6 flox/flox+flox/flox;Tie2-Cre BM, 6 flox/flox;Tie2-Cre+flox/flox
BM and 6 flox/flox;Tie2-Cre+flox/flox;Tie2-Cre BM per timepoint. (C) Collateral lumen
area in ligated hindlimbs 3 weeks after femoral artery ligation surgery. Cross-sections of the
gracilis muscle were H&E stained and collateral lumen area was measured. Quantitation
provided as mean +/− SEM. *= p<0.05. n= 5 flox/flox+flox/flox BM, 4 flox/flox+flox/
flox;Tie2-Cre BM, 4 flox/flox;Tie2-Cre+flox/flox BM and 4 flox/flox;Tie2-Cre+flox/
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flox;Tie2-Cre BM (D) Shc flox/flox or Shc flox/flox; Tie2-Cre MLECs were exposed to shear
stress or left as static controls in the presence of lentivirus-infected THP-1 cells. Monocyte
adhesion to the endothelial monolayer was quantified by counting the number of adherent
monocytes in 5 random fields. These data are presented as mean +/− SEM. *= p<0.05.
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Figure 4. Shc regulates shear stress-induced collateral EC arterial specification via activation of
the Notch pathway
(A) Upregulation of Notch-dependent arterial EC marker ephrinB2 during collateral
arteriole remodeling requires Shc. Staining of collaterals 3 days after femoral artery ligation
(or sham) surgery for ephrinB2 (red), Smooth Muscle α-actin (green) and DAPI (blue). (B)
Activation of Notch transcription factor requires Shc. Staining of collaterals 3 days after
femoral artery ligation (or sham) surgery for Cleaved Notch-1 (red), Smooth Muscle α-actin
(green) and DAPI (blue). (C) Quantitation of (B) displayed as % ECs with nuclear (active)
Cleaved Notch-1 localization. Values are provided as mean +/− SEM. *= p<0.05. n= 8 flox/
flox and 8 flox/flox;Cre. (D&E) Shc is required for shear stress-induced Notch target gene
(D) and Notch ligand (E) expression. Relative mRNA expression of Notch target genes
Ephrin-B2, HES-1 and Deltex or Notch ligands Delta like-1, Delta like-4, Jagged-1 and
Jagged-2 in ECs isolated from flox/flox vs. flox/flox; Tie2-Cre mice. ECs were sheared for 4
hrs at 15 dynes/cm2 or kept static as a control. Values are shown as mean +/− SEM (n=4
independent experiments). *= p<0.05. (F) Upregulation of Notch ligand Dll-4 requires Shc.
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Staining of collaterals 3 days after femoral artery ligation (or sham) surgery for Dll-4 (red),
Smooth Muscle α-actin (green) and DAPI (blue).
(G) Schematic showing the role of Shc during collateral remodeling: onset of shear stress
induces Shc phosphorylation and the association of Shc with components of the
mechanosensory complex (VE-cadherin and VEGFR2) as well as integrins. Shc is required
for shear stress-induced NF-κB activation, downstream cell adhesion molecule upregulation
(VCAM-1) and inflammation (blue arrows). Additionally, Shc is required for shear stress-
induced notch ligand upregulation (Dll-1 and Dll-4), downstream canonical Notch activation
and Notch-target gene expression (ephrin B2, HES-1 and Deltex-1) and arterial specification
(red arrows).
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